<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00199628</url>
  </required_header>
  <id_info>
    <org_study_id>I05001</org_study_id>
    <nct_id>NCT00199628</nct_id>
  </id_info>
  <brief_title>Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization</brief_title>
  <official_title>Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <brief_summary>
    <textblock>
      Problems of compatibility between a mother and her child are frequent. The most well-known
      case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which
      can induce severe anemia of the fetus.

      The investigators recently proved that incompatibility between mother and child can concern
      an organ leading to a tissular alloimmunization. For example, neonatal membranous
      glomerulonephritis (a kidney disease) can result from this mechanism.

      The purpose of this network is to detect and study neonatal diseases induced by tissular
      fetomaternal alloimmunization. The detection of these diseases will be performed by the
      mother's serum analysis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2005</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>100</enrollment>
  <condition>Glomerulonephritis, Membranous</condition>
  <condition>Neonatal Diseases and Abnormalities</condition>
  <condition>Hemochromatosis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Mothers having a child suffering from:

          -  Neonatal membranous glomerulonephritis

          -  Unexplained neonatal tubular defect

          -  Unexplained thrombotic microangiopathy

          -  Neonatal hemochromatosis

        Exclusion Criteria:

          -  Any cause explaining the child's disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Guigonis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics, Limoges University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincent Guigonis, MD</last_name>
    <phone>+33(0)555 056 358</phone>
    <email>vincent.guigonis@chu-limoges.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Limoges University Hospital</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Guigonis, MD</last_name>
      <phone>+33(0) 555 056 358</phone>
      <email>vincent.guigonis@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Guigonis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>March 10, 2006</last_update_submitted>
  <last_update_submitted_qc>March 10, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2006</last_update_posted>
  <keyword>fetomaternal tissular alloimmunization</keyword>
  <keyword>Mothers having a child suffering from:</keyword>
  <keyword>neonatal membranous glomerulonephritis</keyword>
  <keyword>unexplained neonatal tubular defect</keyword>
  <keyword>unexplained thrombotic microangiopathy</keyword>
  <keyword>neonatal hemochromatosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glomerulonephritis</mesh_term>
    <mesh_term>Hemochromatosis</mesh_term>
    <mesh_term>Glomerulonephritis, Membranous</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

